Biomedical & Medtech Manufacturing
Sanofi (Evolutive Vaccine Facility)
UNCLAIMED RECORD · Claim it →A roughly US$590-638 million modular, digitally-enabled vaccine-and-biologics plant at Tuas designed to switch rapidly between up to four vaccines across protein and mRNA platforms — Sanofi's first fully modular vaccine and biologics site in Asia, engineered for pandemic and regional demand, with captive multi-vaccine drug-product filling built in.
Capabilities
Sources
CLAIM THIS RECORD
Is this your company?
Sanofi (Evolutive Vaccine Facility) is on the Singapore Industry Index as a reference record, compiled from public sources. Claiming it is free — correct the facts, add capabilities and certifications, appear on more pages, and receive enquiries routed directly to you.
Spotted an error? Claiming is the fastest way to fix it — or write to us via Contact.